Breschi GL, Demma F, Morelli P, De Francesco M. Brentuximab vedotin in adult patients with HL CD30+ at high risk of relapse or progression following ASCT: a cost-analysis in Italy. AboutOpen [Internet]. 2021 Sep. 2 [cited 2024 Dec. 22];8(1):81-7. Available from: https://journals.aboutscience.eu/index.php/aboutopen/article/view/2263